Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation

Genevieve Bureau1, Fanny Longpré, M-G Martinoli

  • 1Department of Biochemistry and the Neuroscience Group, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.

Insights

Resveratrol and quercetin, natural compounds, reduce neuroinflammation in Parkinson's disease models. They protect dopaminergic neurons from death caused by activated microglia, suggesting potential therapeutic benefits.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Parkinson's disease (PD) involves progressive loss of dopaminergic neurons and is linked to neuroinflammation.
  • Microglia activation and pro-inflammatory cytokines are implicated in PD pathogenesis and neuronal apoptosis.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of resveratrol and quercetin on neuroinflammation.
  • To determine if these polyphenols protect dopaminergic neurons from microglial activation-induced death.

Main Methods:

  • Assessed the impact of resveratrol and quercetin on lipopolysaccharide (LPS)-induced pro-inflammatory gene expression in glial cells.
  • Utilized microglial-neuronal co-cultures to evaluate neuronal cell death.
  • Employed cytotoxicity assays, TdT-mediated dUTP nick end labeling, and cleaved caspase-3 detection to identify apoptotic cells.

Main Results:

  • Resveratrol and quercetin significantly decreased mRNA levels of interleukin 1-alpha and tumor necrosis factor-alpha in glial cells.
  • These polyphenols reduced inflammation-mediated apoptotic death of dopaminergic neurons in co-culture systems.
  • Treatment with resveratrol or quercetin protected neuronal cells from LPS-activated microglia.

Conclusions:

  • Resveratrol and quercetin demonstrate potent anti-inflammatory properties.
  • These natural compounds diminish microglial activation-induced apoptotic neuronal cell death.
  • Resveratrol and quercetin show promise as potential therapeutic agents for Parkinson's disease.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...